AstraZeneca names Zook to head North America

Share this article:
AstraZeneca named Tony Zook executive vice president for North America, succeeding David Brennan, who was named chief executive of the company in July.
 Zook is slated to assume his duties Jan. 1, 2006, as Brennan takes over the reigns from the retiring Sir Tom McKillop, whose leadership began following the 1999 merger of Astra AB and Zeneca.
Currently, Zook serves as AstraZeneca's senior vice president, U.S. commercial operations. 
Share this article:

Email Newsletters

More in News

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Valeant bids $47B for Allergan

Valeant bids $47B for Allergan

The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.